Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Anthony Martinez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants & Projects
- 7 Finished
-
Interdisciplinary Substance Use Disorder Fellowship Training Program
Abdelsayed, S. (PI), Elliott, F. (PI), Doscher, T. (CoI), Kahn, L. (CoI), Linkie, C. (CoI) & Martinez, A. (CoI)
Health Resources and Services Admin
07/1/23 → 06/30/25
Project: Research
-
Patient-Centered HCV Care via Telemedicine for Individuals on Opiate Substitution Therapy: A Stepped Wedge Cluster Randomized Controlled Trial
Talal, A. (PI), Blondell, R. (CoI), Markatou, M. (CoI) & Martinez, A. (CoI)
Patient Centered Outcomes Research Institute (PCORI)
06/1/16 → 06/30/24
Project: Research
-
Efficacy and Safety Study of Cenicriviroc for the treatment of nonalcoholic Steatohepatitis (NASH) in Adult subjects with Liver Fibrosis
Martinez, A. (PI) & Talal, A. (CoI)
01/6/15 → 01/5/20
Project: Research
-
Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis
Cooper, C., Raina, S. A., Johnson, L., Feld, J. J., Brown, A., Martinez, A., Conway, B., Gordon, S. C., Asselah, T., Uribe, L., Li, M., Iacob, A., Marcinak, J., Semizarov, D. & Pol, S., May 2026, In: Infectious Diseases and Therapy. 15, 5, p. 1493-1508 16 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs
Sulkowski, M. S., Martinez, A., Tyson, G. L., Scholz, K., Franco, R. A., Kohli, A., Julius, S. F., Deming, P., Fink, S. A., Lynch, K., Roytman, M., Stainbrook, T. R., Turner, M. D., Viera-Briggs, M. & Ramers, C. B., Jun 2024, In: Journal of Viral Hepatitis. 31, 6, p. 342-356 15 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations
Mukherjee, D., Collins, M., Dylla, D. E., Kaur, J., Semizarov, D., Martinez, A., Conway, B., Khan, T. & Mostafa, N. M., Aug 2023, In: Infectious Diseases and Therapy. 12, 8, p. 2057-2070 14 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients
Reau, N., Cheng, W. H., Shao, Q., Marx, S. E., Brooks, H. & Martinez, A., Jul 2023, In: Infectious Diseases and Therapy. 12, 7, p. 1849-1860 12 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021
Martinez, A., Khan, T., Dylla, D. E., Marcinak, J., Collins, M., Saget, B. & Conway, B., Dec 2023, In: Harm Reduction Journal. 20, 1, 142.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations